{"id":123758,"date":"2025-10-06T01:23:03","date_gmt":"2025-10-06T01:23:03","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-30T00:00:00","slug":"ensuring-compliance-in-the-340b-program-common-pitfalls-and-effective-strategies-for-covered-entities-2077564","status":"publish","type":"post","link":"https:\/\/www.simbo.ai\/blog\/ensuring-compliance-in-the-340b-program-common-pitfalls-and-effective-strategies-for-covered-entities-2077564\/","title":{"rendered":"Ensuring Compliance in the 340B Program: Common Pitfalls and Effective Strategies for Covered Entities"},"content":{"rendered":"

The 340B program needs drug makers to offer outpatient drugs at lower prices to certain healthcare providers called “covered entities.” These include some hospitals like disproportionate share hospitals, children\u2019s hospitals, critical access hospitals, federally qualified health centers (FQHCs), and AIDS drug assistance programs.<\/p>\n

Covered entities get 340B drugs at discounted prices from wholesalers or specialty distributors. The Health Resources and Services Administration (HRSA) sets the maximum price based on the average manufacturer price minus a rebate. Discounts usually range from 20% to 50%, helping covered entities save money on outpatient drugs. This is important when budgets are tight.<\/p>\n

But these discounts only work if covered entities follow many rules set by HRSA\u2019s Office of Pharmacy Affairs (OPA). Not following the rules can lead to audits, fines, and even getting kicked out of the program.<\/p>\n

Compliance Challenges and Common Pitfalls<\/h2>\n

1. Lack of Dedicated Personnel and Administrative Bandwidth<\/h2>\n

One big reason covered entities struggle with the 340B program is they don\u2019t have enough staff to handle it. The program needs people to check who is eligible, update policies, prepare for audits, and keep data accurate.<\/p>\n

Many facilities now hire full-time workers or hire outside companies to manage 340B compliance. These people keep the program running correctly every day. Without them, organizations risk breaking rules and losing savings.<\/p>\n

<\/p>\n

\n

HIPAA-Compliant Voice AI Agents<\/h4>\n

SimboConnect AI Phone Agent encrypts every call end-to-end – zero compliance worries.<\/p>\n

Don\u2019t Wait \u2013 Get Started \u2192<\/a>\n<\/div>\n

<\/p>\n

2. Inadequate Written Policies and Procedures<\/h2>\n

HRSA expects covered entities to have clear written policies that match hospital or clinic rules. These policies should cover patient eligibility, stopping drug misuse, avoiding duplicate discounts, and handling contract pharmacies.<\/p>\n

These policies also need to be checked and updated regularly. Not keeping good and current policies is a big risk in HRSA audits.<\/p>\n

3. Patient Eligibility Errors<\/h2>\n

The 340B program says discounted drugs can only go to eligible patients. A “340B patient” must have a real relationship with the covered entity and get qualifying healthcare, not just a prescription.<\/p>\n

Giving 340B drugs to patients who are not eligible, like those who just got a prescription for self-use, is a violation. Covered entities must keep exact records to prove patient eligibility. Many audits find mistakes here.<\/p>\n

4. Contract Pharmacy Oversight<\/h2>\n

Covered entities sometimes use contract pharmacies to give 340B drugs at many places. While contract pharmacies help with access, managing them is hard. About 81% of covered entities audited in 2019 had contract pharmacies.<\/p>\n

Every contract pharmacy must be registered with HRSA\u2019s OPA before giving 340B drugs. Both sides must sign written agreements. Covered entities must watch these pharmacies to stop drug misuse or duplicate discounts.<\/p>\n

Audits show many problems come from lack of oversight or missing contracts. Sometimes contract pharmacies have to be dropped. Regular audits and checking transactions help keep compliance.<\/p>\n

5. Duplicate Discounts and Product Diversion<\/h2>\n

Duplicate discounts happen if a drug gets both a 340B discount and a Medicaid rebate, which is not allowed. Product diversion means giving 340B drugs outside allowed rules.<\/p>\n

HRSA audits from 2012 to 2019 found many cases of diversion and duplicate discounts. About 38% of covered entities had two or more major problems. These issues can mean paying back money and facing penalties.<\/p>\n

It is important to keep Medicaid billing clear and records correct to avoid duplicate discounts.<\/p>\n

6. Inaccurate Record-Keeping and Data Mismatches<\/h2>\n

Good record-keeping is very important in the 340B program, but many covered entities have data problems. Common mistakes are wrong provider files, outdated pharmacy info, and mismatched patient data like different names or birth dates.<\/p>\n

These errors often happen because entities use many electronic health records (EHRs), third-party administrators (TPAs), and pharmacies. It can cause lost savings, rejected claims, or rule breaks.<\/p>\n

For example, patient names like \u201cJim\u201d instead of \u201cJames\u201d may cause claim problems. Fixing these requires standard data methods and careful database updates.<\/p>\n

7. Complexities in Provider Claim Capture<\/h2>\n

Covered entities must track which health providers\u2019 claims qualify for 340B discounts. Providers can be Exclusive\/Standard, Non-Exclusive\/Non-Standard, or Referral, each with different rules.<\/p>\n

Mistakes in provider classification or not updating provider lists can lead to wrong claims or missed savings. Working closely with TPAs and setting claim systems right helps keep billing accurate and legal.<\/p>\n

Effective Strategies for Maintaining 340B Compliance<\/h2>\n

1. Establish Comprehensive Written Policies and Training<\/h2>\n

Covered entities should create clear 340B policies that fit with their hospital or clinic rules. These policies should cover patient eligibility, contract pharmacy deals, avoiding duplicate discounts, inventory control, and audit steps.<\/p>\n

Regular staff training helps everyone know the rules and their duties. HRSA and contractors like Apexus offer useful training materials.<\/p>\n

2. Use Dedicated 340B Software and Technology Solutions<\/h2>\n

Using special 340B software helps keep provider files, billing info, pharmacy registrations, and drug inventory correct. These systems track data in real time and make reports needed for compliance.<\/p>\n

Advanced inventory systems can count stock, watch dispensing patterns, and mark prescriptions, which lowers mistakes seen in manual work.<\/p>\n

3. Regular Internal Audits and Governance Committees<\/h2>\n

Doing regular audits on contract and in-house pharmacies is a good practice. These reviews find problems early so fixes can happen before HRSA or manufacturer audits.<\/p>\n

Setting up a 340B governance committee helps monitor and manage responsibilities. These groups meet often to check policies, audit results, data quality, and problems.<\/p>\n

4. Contract Pharmacy Management<\/h2>\n